Sagent Pharmaceuticals, Inc. (SGNT) Tops Q3 EPS by 7c, Guides FY
Tweet Send to a Friend
Sagent Pharmaceuticals, Inc. (NASDAQ: SGNT) reported Q3 EPS of ($0.13), $0.07 better than ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
